Make HPV screening easy for everyone
We reduce the number of cervical cancers through empowering individuals’ control over their health
Cervical cancer is the fourth most common cancer in women
HPV-associated cervix cancer accounts for 95% of HPV-attributable cancers
WHO estimates that 74 million new cases of cervical cancer can be averted, and 62 million deaths can be avoided with a good screening
Screening is the way: saving lives one test at a time.
Be the first to know
Sign up for updates on the project
Our team
Serena Petracchini
CSO
- Research Scientist 8y exp
- PhD in microbiology Pasteur Institute
- Development of innovative therapies for UTI Infections
- 10k Seed Grant IP winner
- iGem Competiton: Tutor for Pasteur Paris, gold medal and 5y Judge
- Réseau Biotechno general secretary: bridging academy and private sector
Chiara Cespi Polisiani
CEO
- Entrepreneur
- Marketing & Communication specialist – 8y exp
- Startup World
- Brand&Comm
- Country manager
- Coding skills: @LeWagon
- Founder @Spadella
- Storyteller
Our advisor
Serge Braun
Directeur Scientifique de l’AFM, l’Association Française contre les Myopathies. Président de GENOSAFE. Pharmacien, Docteur en Pharmacologie de l’Université Louis Pasteur de Strasbourg, Membre de l’Académie Nationale de Pharmacie.
He has worked on the HPV vaccine.
Supported by
